Evidence map›Paper›PMID 41069908›Full record

ArticleCureus2025

Severe Pediatric Arterial Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus: A Case Report.

Isabela Jimenez, Hendrick Trelles Sanchez, Scarleth Samantha Gómez, Heidi Zuñiga González, Mishell Estefanía Llerena Vargas, Dajhana Gleidy Di Valverde Bonilla, Carlos Valladares

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Isabela JimenezGeneral Medicine, University of Manizales, Manizales, COL.
Hendrick Trelles SanchezPediatric Rheumatology, Catholic University of Santa María, Arequipa, PER.
Scarleth Samantha GómezPediatric Rheumatology, Catholic University of Honduras, Tegucigalpa, HND.
Heidi Zuñiga GonzálezGeneral Medicine, University of Monterrey, Monterrey, MEX.
Mishell Estefanía Llerena VargasGeneral Medicine, Equinox University of Technology, Quito, ECU.
Dajhana Gleidy Di Valverde BonillaPediatric Rheumatology, Aquino University Bolivia, Santa Cruz, BOL.
Carlos ValladaresInternal Medicine, Robert Wood Johnson (RWJ) Barnabas Health, Toms River, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic, multisystem immune-mediated disease that can affect any organ system. One of its most significant complications is antiphospholipid syndrome (APS), an autoimmune disorder characterized by thrombosis, which typically presents with venous thrombosis in children. We report a 14-year-old previously healthy girl presenting with progressive right foot cyanosis and ulcerative lesions. Examination revealed digital necrosis, absent distal pulses, and delayed capillary refill. Laboratory findings included elevated antiphospholipid antibodies (aPLs), positive antinuclear antibodies (ANAs), hypocomplementemia, prolonged activated partial thromboplastin time (aPTT), and a reactive Venereal Disease Research Laboratory (VDRL) test. Imaging confirmed occlusion of the anterior tibial and peroneal arteries. She was diagnosed with critical limb ischemia due to APS secondary to SLE. Treatment with intravenous methylprednisolone, anticoagulation, antiplatelet agents, and vasoprotective therapy led to significant improvement, avoiding surgical intervention. APS secondary to SLE is uncommon in pediatric patients, and arterial thrombosis is an especially rare initial manifestation. Juvenile SLE often presents with non-specific symptoms such as arthralgias, headache, fever, and weight loss, which were absent in our patient. Instead, initial symptoms included intermittent claudication-like pain and digital necrosis, likely resulting from endothelial cell proliferation, intimal hyperplasia, endothelial dysfunction, platelet activation, and complement consumption, leading to progressive luminal narrowing and thrombosis. The lack of validated pediatric classification criteria for APS secondary to SLE complicates management decisions. This case underscores the importance of early recognition and prompt initiation of anticoagulation, immunosuppression, and vasoprotective therapy to prevent irreversible tissue damage and the need for surgical intervention.

Indexed as

adolescentsantiphospholipid syndromeautoimmune disorderscase reportpediatric rheumatologysystemic lupus erythematosusthrombosisvascular occlusion

Identifiers

PMID41069908
PMCPMC12505779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.